TY - JOUR AU - Fleeman, Nigel AU - Houten, Rachel AU - Chaplin, Marty AU - Beale, Sophie AU - Boland, Angela AU - Dundar, Yenal AU - Greenhalgh, Janette AU - Duarte, Rui AU - Shenoy, Aditya PY - 2019 DA - 2019/12/12 TI - A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine JO - BMC Cancer SP - 1209 VL - 19 IS - 1 AB - Treatment with radioactive iodine is effective for many patients with progressive, locally advanced or metastatic, differentiated thyroid cancer. However, some patients become refractory to treatment. These types of patients are considered to have radioactive iodine refractory differentiated thyroid cancer (RR-DTC). SN - 1471-2407 UR - https://doi.org/10.1186/s12885-019-6369-7 DO - 10.1186/s12885-019-6369-7 ID - Fleeman2019 ER -